Biomarkers and Genomic Medicine

Biomarkers and Genomic Medicine (BGM), previously Genomic Medicine, Biomarkers and Health Sciences (GMBHS), is the official peer-reviewed publication of the Taiwan Genomic Medicine and Biomarker Society and published quarterly by Elsevier. It is indexed/abstracted in Chemical Abstracts Service, EMBASE, EMCARE, and SCOPUS. BGM is an interdisciplinary open access journal that focuses on providing prompt publication of results from original research on fundamental and applied aspects of genomic science.

With both regional and international authorship and readership in multidisciplinary interests, BGM strives to publish and disseminate new research information reflecting the global view and progress of biomarkers and genomic medicine.

The fields of interest include the following:

  • Genomic medicine
  • Biomarkers
  • Cell signaling
  • Biotechnology
  • Pharmacogenomics
  • Health sciences

In additional to reviews and original articles, BGM accepts short communications, case reports, letters to the editor, recommendations and commentaries to present diversity and emerging research knowledge in genomic medicine.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Journal metrics

  • Imprint: ELSEVIER
  • ISSN: 2214-0247